Since a relationship between TP53 status and tumour sensitivity to TNF-α was previously reported in a human breast cancer model [18], [19], and given that drugs restoring p53 function are now available, we investigated the impact of p53 in the context of resistance to TNF-α in STS cell lines. Here, TP53 is linked to breast carcinoma.